The Campaign for Sustainable Rx Pricing today announced that AARP has joined its effort to find market-based solutions to the problems caused by high-priced prescription medicines. “Although older Americans are particularly vulnerable to high prescription drug costs, this problem has serious health and financial implications for all Americans,” said AARP Chief Public Policy Officer Debra Whitman. “By working together, we can help identify sensible solutions to rising drug prices that balance affordability with the need for continued innovation in the pharmaceutical industry.” AHA joined the campaign in August 2014 and is a member of its steering committee.

Related News Articles

Headline
The Senate Committee on Health, Education, Labor and Pensions today held the second in a series of hearings on the cost of prescription drugs. “We…
Headline
The Senate Finance Committee today held a hearing on issues impacting health care costs and coverage. Witnesses included former Centers for Medicare &…
Headline
President Trump Friday signed into law the FDA Reauthorization Act (H.R. 2430). The bill reauthorizes and amends four FDA user fee programs under which…
Headline
The average monthly premium for a basic Medicare Part D prescription drug plan in 2018 is estimated to be $33.50 per month – or approximately $1.20 less…
Headline
The Senate yesterday voted 94-1 to approve the FDA Reauthorization Act (H.R. 2430), sending the legislation to the president for his signature. The bill…
Headline
Senate Democratic Leader Charles Schumer and House Democratic Leader Nancy Pelosi today unveiled an economic plan focused on improving wages, lowering costs…